NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-28 13:24இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Diamines & Chemicals Q2 Net Loss Widens to ₹1.70 Cr; Revenue Down 31% QoQ to ₹9.84 Cr
Diamines & Chemicals reported a standalone net loss of ₹1.70 crore for Q2 FY27 (quarter ended September 30, 2026), worsening from a profit of ₹0.27 crore in Q1 FY27, though narrowing from a loss of ₹3.70 crore in Q2 FY26. Revenue from operations dropped 31.5% QoQ to ₹9.84 crore compared to ₹14.37 crore in Q1 FY27, while up modestly by 5.8% YoY from ₹9.30 crore. The group formally discontinued its trading operations in the fruits and vegetables segment, moving forward exclusively in Specialty Chemicals.
உச்சம் நம்பிக்கை
என்ன மாறியதுDiamines & Chemicals reported its Q2 FY27 financials, slipping back to a net loss of ₹1.70 crore from a small profit last quarter, while formally discontinuing its legacy agri-trading segment.
ஏன் இது முக்கியம்The company continues to face margin and revenue pressure stemming from a persistent global demand-supply imbalance and weak pricing power in ethylene amines.
Revenue from Operations (Q2): ₹984.37 லட்சம்Net Loss (Q2): ₹169.58 லட்சம்Total Income (Q2): ₹1,068.63 லட்சம்Cost of Materials Consumed (Q2): ₹407.86 லட்சம்Revenue vs TTM Revenue: ~24.0%
📅 குறுகிய காலம்Quarterly operational reversal from small profitability back into losses may dampen near-term market sentiment.
📈 நீண்ட காலம்Long-term recovery hinges on the resolution of global supply glut in ethylene amines and successful operational execution at the Dahej facility.
⚠ அபாய எச்சரிக்கைகள்
Continued negative operating profitability and pricing pressure
Revenue volatility and high dependence on single Specialty Chemicals product family
Sluggish inventory movement amid global demand-supply imbalance
👀 கவனிக்க வேண்டியவை
Track whether sales volumes and realizations in ethylene amines stabilize in upcoming quarters, and watch for progress on Dahej site investments.
Subsidiary DACL Fine Chem Receives APPCB Consent to Establish for Specialty Amines Plant
Diamines & Chemicals Limited announced that its wholly owned subsidiary, DACL Fine Chem Limited, received Consent to Establish (CTE) from the Andhra Pradesh Pollution Control Board on October 15, 2026. The approval is for establishing a proposed plant for Specialty Amines and Chemicals in Kakinada District, Andhra Pradesh. The CTE is valid for 7 years until October 14, 2033. This marks a key regulatory milestone to expand production beyond its existing base, amid Diamines' TTM revenue of ₹41 Cr and TTM net loss of ₹10 Cr.
உச்சம் நம்பிக்கை
என்ன மாறியதுWholly owned subsidiary DACL Fine Chem received formal environmental CTE approval to set up a new manufacturing plant in Andhra Pradesh.
ஏன் இது முக்கியம்Enables the company to begin site construction and setup for specialty amines, essential for broadening its product portfolio and recovering from recent operational losses.
CTE Validity Period: 07 years up to 14/10/2033Approval Date: அக்டோபர் 15, 2026Proposed Plant Capex / Capacity: வெளியிடப்படவில்லை
📅 குறுகிய காலம்Clearance removes initial regulatory hurdles, though immediate financial impact is limited until construction commences.
📈 நீண்ட காலம்Could significantly expand manufacturing capacity and support a turnaround if new specialty chemical products achieve commercial viability.
⚠ அபாய எச்சரிக்கைகள்
Capex quantum, capacity metrics, and commissioning timelines not disclosed
Execution and financing risks given negative TTM margins (-23.3%)
Diamines & Chemicals (DACL) returned to profitability in Q1 FY27, posting a net profit of ₹0.27 Cr compared to a loss of ₹2.39 Cr in the same quarter last year. The Board approved a significant ₹40 Cr additional investment in its wholly-owned subsidiary, DACL Fine Chem Limited, to be funded via internal accruals and liquid funds. This investment is highly material, representing approximately 105% of the company's TTM revenue. While the company's new project has reached mechanical completion, commercial production is currently delayed due to ongoing optimization of the distillation process.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has moved from a loss-making phase to a marginal profit and has committed a capital amount exceeding its annual revenue into its subsidiary for expansion.
ஏன் இது முக்கியம்The ₹40 Cr investment is a major scale-up move for a company with a ₹272 Cr market cap and ₹38 Cr TTM revenue, signaling a pivot toward growth through its subsidiary despite current pricing pressures in the chemicals industry.
Q1 FY27 Revenue: ₹14.37 கோடிQ1 FY27 Net Profit: ₹0.27 கோடிSubsidiary Investment: ₹40 கோடிInvestment vs TTM Revenue: 105.2%Investment vs Net Worth: 24.4%
📅 குறுகிய காலம்The return to profitability and the announcement of a large capital commitment are likely to be viewed positively by the market in the coming weeks.
📈 நீண்ட காலம்The long-term trajectory depends on the successful commissioning of the distillation process and the ability of the subsidiary to generate returns on the ₹40 Cr investment.
⚠ அபாய எச்சரிக்கைகள்
Delay in commercial production due to process optimization
High capital commitment relative to current revenue base
👀 கவனிக்க வேண்டியவை
Investors should monitor the timeline for the commencement of commercial production at the new project site and the specific deployment of the ₹40 Cr capital in the subsidiary.
₹40 Cr Land Acquisition for New Chemical Plant by Diamines & Chemicals Subsidiary
DACL Fine Chem Limited, a wholly-owned subsidiary of Diamines & Chemicals, has signed a binding term sheet to acquire approximately 50 acres of freehold industrial land in Kakinada, Andhra Pradesh. The total land consideration is ₹40 crore (₹28 cr for Tranche 1 and ₹12 cr for Tranche 2), which is highly significant as it exceeds the company's TTM revenue of ₹38 crore. The land is intended for a new chemical plant, signaling a major capacity expansion despite the company reporting a TTM PAT loss of ₹13 crore. The term sheet remains valid until June 30, 2027, pending the execution of a definitive agreement.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has moved from planning to a binding commitment to acquire a large land parcel for a new manufacturing facility through its subsidiary.
ஏன் இது முக்கியம்This is a massive scale-up relative to the company's current size; the land cost alone is 24% of its net worth and 105% of annual revenue, indicating a potential structural shift in the business if successfully executed.
Total Land Cost: ₹40 கோடிLand Cost vs TTM Revenue: ~105%Land Cost vs Net Worth: ~24.4%Land Area: 50 acresTerm Sheet Validity: ஜூன் 30, 2027
📅 குறுகிய காலம்The market may view the expansion intent positively, but concerns regarding the funding of a ₹40 cr land deal plus plant capex while the company is loss-making may limit immediate upside.
📈 நீண்ட காலம்If the new plant successfully addresses the global demand-supply imbalance mentioned in filings, it could significantly re-rate the company's small revenue base over the next 3-5 years.
⚠ அபாய எச்சரிக்கைகள்
Funding risk for capex given TTM PAT of -₹13 Cr
Execution risk for a project of this magnitude relative to current operations
Long lead time for definitive agreement (June 2027)
👀 கவனிக்க வேண்டியவை
Monitor the company's funding strategy for this land purchase and subsequent plant construction, especially given the current negative operating margins (-35.9%) and cash flow constraints.
Diamines & Chemicals Reports Zero Fund Deviation; Significant Warrants Lapse in Q4 FY26
Diamines & Chemicals Limited (DACL) has reported no deviation or variation in the utilization of funds raised through its preferential issue for the quarter ended March 31, 2026. While the company originally planned to raise up to Rs 50.58 crore, only 2,69,402 warrants were converted into equity shares, bringing in Rs 11.15 crore (75% exercise money) in March 2026. The remaining warrants from the original 9,06,390 allotment have lapsed as of the March 31 deadline. The funds received are being directed toward capital expenditure, working capital, and general corporate purposes.
முக்கிய அம்சங்கள்
Confirmed zero deviation in the utilization of funds as per the objects of the preferential issue.Allotted 2,69,402 equity shares on March 24, 2026, following the receipt of Rs 11.15 crore in exercise money.The company had previously received Rs 12.51 crore as the initial 25% subscription for 9,06,390 warrants in October 2024.Remaining warrants lapsed on March 31, 2026, meaning the company did not realize the full potential capital of Rs 50.58 crore.Funds are earmarked for CAPEX, working capital requirements, and technology investments.
👀 கவனிக்க வேண்டியவை
While the lack of fund deviation is positive for corporate governance, investors should monitor if the lapsing of a majority of the warrants affects the company's planned expansion or CAPEX timelines due to lower-than-expected capital inflow.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Diamines & Chemicals Reports FY26 Net Loss and Re-appoints Key Leadership
Diamines & Chemicals Limited approved its audited financial results for the year ended March 31, 2026, which notably reported a net loss. The board has re-appointed Mr. Tanmay Godiawala as Executive Director and Mr. Rajendra Chhabra as Non-Executive Director for three-year terms starting in late 2026 and early 2027. Additionally, the company has overhauled its audit team by appointing new cost, internal, and tax auditors for FY 2026-27. The board also approved a commission-based remuneration structure for non-executive directors for the next five years.
முக்கிய அம்சங்கள்
Audited financial results for FY26 confirmed a net loss for the standalone and consolidated entities.Mr. Tanmay Godiawala re-appointed as Executive Director for a 3-year term starting February 6, 2027.Mr. Rajendra Chhabra re-appointed as Professional Non-Executive Director for 3 years starting November 6, 2026.New auditors appointed for FY27: S S Puranik & Associates (Cost), CNK & Associates LLP (Internal), and K. C. Mehta & Co. LLP (Tax).Approved remuneration for Rajendra Chhabra exceeding 50% of the total non-executive director compensation pool for FY27 and FY28.
👀 கவனிக்க வேண்டியவை
Investors should carefully review the detailed financial statements to identify the drivers behind the reported net loss. Maintain a cautious stance until the company provides a clear outlook for returning to profitability.
Diamines & Chemicals Forfeits ₹8.79 Cr as 6.37 Lakh Warrants Lapse
Diamines & Chemicals Limited announced that 6,36,988 convertible warrants have lapsed as holders failed to exercise their conversion option by the March 31, 2026 deadline. Consequently, the company has forfeited the initial 25% subscription amount of ₹8.79 crore (₹138 per warrant). Out of the 9,06,390 warrants originally allotted in October 2024 at an issue price of ₹552, only 2,69,402 were converted into equity. Notably, the promoter group chose not to convert 3,23,388 warrants, which represents a significant portion of the lapsed instruments.
முக்கிய அம்சங்கள்
6,36,988 warrants lapsed out of 9,06,390 initially allotted on October 1, 2024.Company forfeited ₹8.79 crore, representing the 25% upfront payment for the lapsed warrants.Promoter group failed to convert 3,23,388 warrants, while non-promoters let 3,13,600 warrants lapse.The conversion price was set at ₹552 per warrant, and only 29.7% of the total issue was converted.The company misses out on approximately ₹26.37 crore in anticipated capital from the remaining 75% payment.
👀 கவனிக்க வேண்டியவை
Investors should view the promoter's decision not to exercise warrants at ₹552 as a cautious signal regarding the stock's valuation. Monitor the current market price relative to the strike price to understand the lack of conversion interest.
Diamines & Chemicals Receives Disclosure Under SEBI SAST Regulations
Diamines & Chemicals Limited has informed the stock exchanges about a disclosure received under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This specific regulation mandates disclosure when there is a change in shareholding exceeding 2% or when a promoter's holding changes. The disclosure was received by the company on March 25 and subsequently reported to the BSE and NSE. Such filings are key indicators of significant shifts in ownership or promoter confidence.
முக்கிய அம்சங்கள்
Company received disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) RegulationsNotification submitted to BSE (Scrip Code: 500120) and NSE (Symbol: DIAMINESQ) on March 26, 2025The disclosure pertains to a transaction or change in holding reported on March 25Regulation 29(2) filings typically involve transactions by promoters or major institutional investors
👀 கவனிக்க வேண்டியவை
Investors should check the detailed SAST filing on the exchange websites to identify the specific party involved and whether they were buying or selling. Promoter acquisitions are generally viewed as a positive signal of internal confidence.
Diamines & Chemicals Limited has approved the conversion of 2,69,402 warrants into an equal number of equity shares following the receipt of the 75% balance payment. This exercise has resulted in a capital infusion of approximately Rs. 11.15 crore into the company. The conversion was primarily driven by promoter group entities, including the Mehta family and associated companies, indicating strong promoter commitment. Following this allotment, the company's total paid-up equity capital has increased to Rs. 10.05 crore, with 6,36,988 warrants still pending for future conversion.
முக்கிய அம்சங்கள்
Conversion of 2,69,402 warrants into equity shares at a total issue price of Rs. 552 per share.Receipt of Rs. 11.15 crore representing the 75% balance exercise price (Rs. 414 per warrant).Promoter group entities dominated the conversion, including Amit Mehta and S Amit Speciality Chemicals.Total paid-up equity shares increased from 97,83,990 to 1,00,53,392 shares.6,36,988 warrants remain outstanding and must be converted within 18 months of their original allotment.
👀 கவனிக்க வேண்டியவை
The conversion of warrants by promoters at a price of Rs. 552 per share reflects management's confidence in the company's long-term prospects. Investors should monitor the utilization of the newly raised capital and the eventual conversion of the remaining warrants.
Diamines & Chemicals Q3 FY26: Net Loss Widens to ₹192.55 Lakhs as Revenue Drops 56% YoY
Diamines & Chemicals Limited reported a significant downturn in its Q3 FY26 results, with standalone revenue falling 56.4% YoY to ₹763.57 Lakhs. The company recorded a net loss of ₹192.55 Lakhs for the quarter, a sharp increase from the ₹15.34 Lakhs loss in the previous year's corresponding quarter. For the nine-month period, the company reported a total loss of ₹901.97 Lakhs compared to a profit of ₹287.07 Lakhs in the prior year. The decline is primarily attributed to poor performance in the Specialty Chemicals segment, which saw its segment results turn into a loss.
முக்கிய அம்சங்கள்
Standalone Revenue from Operations fell to ₹763.57 Lakhs in Q3 FY26 from ₹1,751.41 Lakhs in Q3 FY25.Net loss for the nine months ended Dec 31, 2025, stood at ₹901.97 Lakhs compared to a profit of ₹287.07 Lakhs in the previous year.Specialty Chemicals segment loss before tax and finance costs was ₹290.20 Lakhs for the quarter.Total expenses for the quarter were ₹1,139.19 Lakhs, significantly exceeding the total income of ₹835.63 Lakhs.The company made a provision of ₹4.62 Lakhs towards the impact of new Labour Codes effective from November 2025.
👀 கவனிக்க வேண்டியவை
The sharp decline in revenue and transition to significant losses indicate severe operational headwinds in the specialty chemicals sector. Investors should remain cautious and wait for signs of margin recovery or improved demand before considering any fresh investments.
Diamines & Chemicals Gets GPCB Approval for Product Mix Amendment to Boost Production Capacity
Diamines & Chemicals Limited has received a Consolidated Consent & Authorization (CC&A) amendment from the Gujarat Pollution Control Board (GPCB) on January 21, 2026. This regulatory approval allows the company to modify its product mix and set up new industrial activities within its existing manufacturing unit in Vadodara. The management expects this move to facilitate the production of new items and contribute to an overall increase in total production capacity. The license is valid until September 30, 2027, providing a clear operational runway for the planned expansion.
முக்கிய அம்சங்கள்
Received CC&A Amendment from Gujarat Pollution Control Board (GPCB) on January 21, 2026Approval enables setting up of new industrial plant/activities within the existing manufacturing unitThe amendment allows for a revised product mix, leading to an increase in total production capacityThe regulatory license (Order AWH-151692) is valid for a period ending September 30, 2027
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step toward volume growth and monitor the company's timeline for the commencement of new product manufacturing.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
